Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center/NY Presbyterian Hospital
mi
from
New York, NY
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center/NY Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati UC Health University Hospital
mi
from
Cincinnati, OH
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati UC Health University Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Geisinger Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Minnesota Epilepsy Group
mi
from
Saint Paul, MN
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Minnesota Epilepsy Group
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health - Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Maternal and Neurodevelopmental Outcomes of in Utero Antiepileptic Drug (AED) Exposure
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health - Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of L-Serine in Subjects With Hereditary Sensory Neuropathy Type 1
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of L-Serine in Subjects With Hereditary Sensory Neuropathy Type 1
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of L-Serine in Subjects With Hereditary Sensory Neuropathy Type 1
Status: Enrolling
Updated:  12/31/1969
UMASS Medical Center
mi
from
Worcester, MA
L-Serine Supplementation in Hereditary Sensory Neuropathy Type 1
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of L-Serine in Subjects With Hereditary Sensory Neuropathy Type 1
Status: Enrolling
Updated: 12/31/1969
UMASS Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
University of California Davis
mi
from
Davis, CA
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Childrens National Medical Center
mi
from
Washington,
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital
mi
from
Kansas City, MO
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
State University of New York, Upstate Medical Center
mi
from
Syracuse, NY
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
State University of New York, Upstate Medical Center
mi
from
Syracuse, NY
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Doernbecher Children's Hospital
mi
from
Portland, OR
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Doernbecher Children's Hospital
mi
from
Portland, OR
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated:  12/31/1969
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Spinal Muscular Atrophy (SMA) Biomarkers in the Immediate Postnatal Period of Development
Status: Enrolling
Updated: 12/31/1969
University of Utah Health Sciences Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
The University of California Irvine
mi
from
Orange, CA
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
The University of California Irvine
mi
from
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University/Bayview Medical Center
mi
from
Baltimore, MD
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University/Bayview Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Boston University School of Medicine - Amyloid Treatment & Research Program
mi
from
Boston, MA
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Boston University School of Medicine - Amyloid Treatment & Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center Neurological Institute
mi
from
New York, NY
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center Neurological Institute
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
Penn Presbyterian Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated:  12/31/1969
FLENI
mi
from
Buenos Aires,
Efficacy and Safety of Inotersen in Familial Amyloid Polyneuropathy
A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ISIS 420915 in Patients With Familial Amyloid Polyneuropathy (NEURO-TTR Study)
Status: Enrolling
Updated: 12/31/1969
FLENI
mi
from
Buenos Aires,
Click here to add this to my saved trials
Living With Frontotemporal Dementia
Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Living With Frontotemporal Dementia
Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Living With Frontotemporal Dementia
Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual
Status: Enrolling
Updated:  12/31/1969
Columbia University
mi
from
New York, NY
Living With Frontotemporal Dementia
Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual
Status: Enrolling
Updated: 12/31/1969
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Living With Frontotemporal Dementia
Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual
Status: Enrolling
Updated:  12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Living With Frontotemporal Dementia
Challenges of Living With Frontotemporal Dementia: The Perspective of the Affected Individual
Status: Enrolling
Updated: 12/31/1969
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism
Effect of Aging and Aerobic Exercise Training on Brain Glucose Metabolism
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism
Effect of Aging and Aerobic Exercise Training on Brain Glucose Metabolism
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
CAPABLE for Frail Dually Eligible Older Adults
CAPABLE for Frail Dually Eligible Older Adults
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University School of Nursing
mi
from
Baltimore, MD
CAPABLE for Frail Dually Eligible Older Adults
CAPABLE for Frail Dually Eligible Older Adults
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University School of Nursing
mi
from
Baltimore, MD
Click here to add this to my saved trials
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Donepezil Compared to Placebo in Patients With Chronic Neuropathic Pain
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated:  12/31/1969
Weill Cornell Medical College
mi
from
White Plains, NY
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated: 12/31/1969
Weill Cornell Medical College
mi
from
White Plains, NY
Click here to add this to my saved trials
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Adaptive Interventions for Minimally Verbal Children With ASD in the Community
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of California, San Diego Medical Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Indiana University School of Medicine
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation.
A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials